NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,126 filers reported holding NOVARTIS A G in Q1 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,606,647 | +1.5% | 35,407 | +0.5% | 0.94% | +4.7% |
Q2 2023 | $3,553,534 | +11.3% | 35,214 | +1.5% | 0.90% | +7.0% |
Q1 2023 | $3,192,113 | +3.2% | 34,696 | +1.7% | 0.84% | +0.8% |
Q4 2022 | $3,094,267 | +19.3% | 34,108 | -0.0% | 0.84% | +7.5% |
Q3 2022 | $2,593,000 | -8.2% | 34,110 | +2.1% | 0.78% | -5.4% |
Q2 2022 | $2,824,000 | +41.7% | 33,412 | +46.4% | 0.82% | +68.4% |
Q1 2022 | $1,993,000 | +8.6% | 22,817 | +8.7% | 0.49% | -3.6% |
Q4 2021 | $1,835,000 | +11.3% | 20,982 | +4.1% | 0.51% | -1.6% |
Q3 2021 | $1,648,000 | -1.3% | 20,149 | +10.2% | 0.51% | -4.8% |
Q2 2021 | $1,669,000 | +13.5% | 18,292 | +6.4% | 0.54% | +1.1% |
Q1 2021 | $1,470,000 | -7.5% | 17,197 | +2.2% | 0.53% | -17.7% |
Q4 2020 | $1,589,000 | +20.9% | 16,825 | +11.4% | 0.65% | -6.3% |
Q3 2020 | $1,314,000 | +2.9% | 15,110 | +3.3% | 0.69% | -4.3% |
Q2 2020 | $1,277,000 | +5.0% | 14,622 | -0.8% | 0.72% | -1.1% |
Q1 2020 | $1,216,000 | +30300.0% | 14,744 | +32664.4% | 0.73% | +24300.0% |
Q4 2017 | $4,000 | – | 45 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |